Financial Network Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Network Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.5K	Buy	178 +79	+80%	+$36.8K	0.08%	198
2025 Q4	$44.9K	Buy	99 +13	+15%	+$5.6K	0.05%	283
2025 Q3	$33.7K	Buy	86 +29	+51%	+$12.1K	0.04%	315
2025 Q2	$25.4K	Buy	57 +7	+14%	+$3.23K	0.03%	336
2025 Q1	$24.2K	Buy	50 +15	+43%	+$6.99K	0.03%	322
2024 Q4	$14.1K	Sell	35 -8	-19%	-$3.71K	0.03%	283
2024 Q3	$20K	Buy	43 +9	+26%	+$4.32K	0.02%	364
2024 Q2	$15.9K	Buy	+34	New	+$14.8K	0.01%	428

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial Network Wealth Advisors's VRTX Position: Q1 2026 in Review

Financial Network Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 80% in Q1 2026, buying an estimated $36.8K and bringing the position to 178 shares worth $79.5K. The position accounts for 0.08% of the portfolio, ranked #198.

Financial Network Wealth Advisors first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Financial Network Wealth Advisors held 178 shares of Vertex Pharmaceuticals worth $79.5K as of Q1 2026.
Financial Network Wealth Advisors bought 79 Vertex Pharmaceuticals shares in Q1 2026, an estimated $36.8K.
Vertex Pharmaceuticals made up 0.08% of Financial Network Wealth Advisors's portfolio in Q1 2026, its #198 holding.
Financial Network Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.